The confirmation of Alex Azar as Secretary of the Department of Health and Human Services provides new opportunities for an experienced public servant to continue work that he began when, as HHS general counsel and as the department’s deputy Secretary, he played pivotal roles in creating the Office of Public Health Preparedness and Response.
The January 17 Senate Health, Education, Labor and Pensions Committee hearing in preparation for reauthorization of the Pandemic and All Hazards Preparedness Act provides a valuable opportunity to consider how best to ensure that states, communities and healthcare facilities have the resources they need to protect against emerging public health threats.
The Better Care Reconciliation Act of 2017 under consideration in the Senate would repeal the Prevention and Public Health Fund in FY2018, a source of support for essential public health activities.
The Infectious Diseases Society of America (IDSA) is deeply concerned that the proposed American Health Care Act under consideration in Congress would repeal the Prevention and Public Health Fund.
The Infectious Diseases Society of America (IDSA) welcomes the action taken by Congress to prevent a government shutdown and provide $1.1 billion for responses to the continuing spread of the Zika virus.
The Infectious Diseases Society of America (IDSA) is pleased that the Senate Health, Education, Labor and Pensions (HELP)” Committee has scheduled the hearing, “Laboratory Testing in the Era of Precision Medicine,” for September 20, 2016.
More than 500 members of the Infectious Diseases Society of America, its HIV Medicine Association and the Pediatric Infectious Diseases Society call on all presidential candidates to commit themselves to public health policies, programs, and investments in a bipartisan aimed petition.
A device designed to improve adherence to outpatient parenteral antimicrobial therapy (OPAT) took top prize at the second IDEA Incubator, a competition showcasing inventions, products and devices to improve patient care for infectious diseases, which takes place during IDWeek.
As 12,000 medical doctors, research scientists and public health experts on the front lines of COVID-19, the infectious diseases community will not be silenced nor sidelined amidst a global pandemic. Reports of a campaign to discredit and diminish the role of Dr. Fauci at this perilous moment are disturbing.
While the data to date show some positive signals that convalescent plasma can be helpful in treating individuals with COVID-19, especially if given early in the trajectory of disease, we lack the randomized controlled trial data we need to better understand its utility in COVID-19 treatment.
The Senate Labor, Health and Human Services and State and Foreign Operations Appropriations bills released by the full committee on Nov. 10 provide needed resources to address infectious diseases in the United States and abroad
A paper published Thursday in Clinical Infectious Diseases examines how barriers to appropriate diagnostic tools led to missed opportunities to curb antibiotic resistance and recommends steps to develop and expand the use of tests that can identify resistant bacteria.